Physician

Adriana C. Rossi, MD

According to 2025 Medicare claims, Adriana Rossi, MD (NPI: 1386847721) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (NPI: 1750649612; TIN: 611661781) and primary practice location at 10029-6501. Rossi is affiliated with the NewYork Quality Care (ACO ID: A2571) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Rossi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 220 traditional Medicare patients, billed 665 HCPCS/CPT codes, and received $75,028 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 275 prescription claims across 61 beneficiaries totaling $31,330 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 67 records totaling $461,168. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $311,151 to $75,028. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $134,205 and ending at $31,330. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	210	10,275	$311,151
2016	269	31,906	$1,230,440
2017	280	68,708	$2,079,860
2018	287	82,225	$2,290,196
2019	293	74,751	$2,418,165
2020	242	51,036	$1,897,506
2021	221	33,113	$1,180,456
2022	177	700	$84,519
2023	207	806	$96,386
2024	220	665	$75,028

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	141	$134,205
2016	55	372	$269,728
2017	77	378	$769,733
2018	79	408	$1,462,567
2019	76	394	$756,344
2020	68	417	$1,150,399
2021	35	86	$230,010
2022	48	230	$236,324
2023	52	300	$193,687
2024	61	275	$31,330

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	15	15	$150
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	26	26	$144
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	196	449	$117
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	42	136	$102
99238	Hospital discharge day management, 30 minutes or less	13	15	$70

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	12	360	$8,056
Atovaquone	Atovaquone	18	322	$6,498
Oxycodone Hcl	Oxycodone Hcl	20	351	$2,885
Valacyclovir	Valacyclovir Hcl	45	2,505	$1,322
Acyclovir	Acyclovir	64	3,235	$1,016

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$33,638	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	38	$427,529	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adriana C. Rossi, MD?

Tedicare shows public-source Medicare data for Adriana C. Rossi, MD (NPI 1386847721), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana C. Rossi, MD have ACO affiliation data?

Adriana C. Rossi, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Adriana C. Rossi, MD?

Adriana C. Rossi, MD is linked to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (billing NPI 1750649612) in the available physician profile data.

Does Adriana C. Rossi, MD have Open Payments data?

Adriana C. Rossi, MD has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.